Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking

American Journal of Psychiatry

Volumn 168, Issue 3, 2011, Pages 265-275

  Johnson, Bankole A ^a   Ait Daoud, Nassima ^a   Seneviratne, Chamindi ^a   Roache, John D ^a   Javors, Martin A ^a   Wang, Xin Qun ^a   Liu, Lei ^a   Penberthy, J Kim ^a   DiClemente, Carlo C ^a   Li, Ming D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ONDANSETRON; PLACEBO; SEROTONIN TRANSPORTER;

3' UNTRANSLATED REGION; ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLISM; APPETITE DISORDER; ARTICLE; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; FATIGUE; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROMOTER REGION; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALCOHOL DRINKING; ALCOHOLISM; COGNITIVE THERAPY; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ONDANSETRON; POLYMORPHISM, SINGLE NUCLEOTIDE; SEROTONIN ANTAGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 79952711338     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2010.10050755     Document Type: Article

References (55)

1. Cargiulo T: Understanding the health impact of alcohol dependence. Am J Health Syst Pharm 2007; 64(suppl 3):S5-S11
2. Szumlinski KK, Diab ME, Friedman R, Henze LM, Lominac KD, Bowers MS: Accumbens neurochemical adaptations produced by binge-like alcohol consumption. Psychopharmacology (Berl) 2007; 190:415-431 (Pubitemid 46204459)
3. Johnson BA, Javors MA, Roache JD, Seneviratne C, Bergeson SE, Ait-Daoud N, Dawes MA, Ma JZ: Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking? Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:209-216
4. Johnson BA: Serotonergic agents and alcoholism treatment: rebirth of the subtype concept: an hypothesis. Alcohol Clin Exp Res 2000; 24:1597-1601
5. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD: Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 1993; 90:2542-2546 (Pubitemid 23078664)
6. Esterling LE, Yoshikawa T, Turner G, Badner JA, Bengel D, Gershon ES, Berrettini WH, Detera-Wadleigh SD: Serotonin transporter (5-HTT) gene and bipolar affective disorder. Am J Med Genet 1998; 81:37-40 (Pubitemid 28114848)
7. D'Souza UM, Craig IW: Functional polymorphisms in dopamine and serotonin pathway genes. Hum Mutat 2006; 27:1-13 (Pubitemid 43045703)
8. Williams LM, Gatt JM, Schofield PR, Olivieri G, Peduto A, Gordon E: "Negativity bias" in risk for depression and anxiety: brain-body fear circuitry correlates, 5-HTT-LPR, and early life stress. Neuroimage 2009; 47:804-814
9. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301:386-389 (Pubitemid 36877077)
10. Bloch MH, Landeros-Weisenberger A, Sen S, Dombrowski P, Kelmendi B, Coric V, Pittenger C, Leckman JF: Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:850-858
11. Huezo-Diaz P, Uher R, Smith R, Rietschel M, Henigsberg N, Marusic A, Mors O, Maier W, Hauser J, Souery D, Placentino A, Zobel A, Larsen ER, Czerski PM, Gupta B, Hoda F, Perroud N, Farmer A, Craig I, Aitchison KJ, McGuffin P: Moderation of antidepressant response by the serotonin transporter gene. Br J Psychiatry 2009; 195:30-38
12. Li MD, Burmeister M: New insights into the genetics of addiction. Nat Rev Genet 2009; 10:225-231
13. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL: Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 1999; 88:83-87 (Pubitemid 29075327)
14. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274:1527-1531 (Pubitemid 26403928)
15. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D, Linnoila M, Weinberger DR: A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 2000; 47:643-649 (Pubitemid 30169258)
16. Javors MA, Seneviratne C, Roache JD, Ait-Daoud N, Bergeson SE, Walss-Bass MC, Akhtar FZ, Johnson BA: Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29:7-13 (Pubitemid 40018200)
17. Seneviratne C, Huang W, Ait-Daoud N, Li MD, Johnson BA: Characterization of a functional polymorphism in the 3′ UTR of SLC6A4 and its association with drinking intensity. Alcohol Clin Exp Res 2009; 33:332-339
18. Chen K, Rajewsky N: Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet 2006; 38:1452-1456 (Pubitemid 44837570)
19. Battersby S, Ogilvie AD, Blackwood DH, Shen S, Muqit MM, Muir WJ, Teague P, Goodwin GM, Harmar AJ: Presence of multiple functional polyadenylation signals and a single nucleotide polymorphism in the 3′ untranslated region of the human serotonin transporter gene. J Neurochem 1999; 72:1384-1388 (Pubitemid 29140806)
20. Beaudoing E, Freier S, Wyatt JR, Claverie JM, Gautheret D: Patterns of variant polyadenylation signal usage in human genes. Genome Res 2000; 10:1001-1010 (Pubitemid 30608635)
21. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, DelProposto ZS, Hill E, Cassin BJ, Watson SJ, Cook EH: Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 1998; 155:207-213 (Pubitemid 28074282)
22. Ait-Daoud N, Roache JD, Dawes MA, Liu L, Wang X-Q, Javors MA, Seneviratne C, Johnson BA: Can serotonin transporter genotype predict craving in alcoholism? Alcohol Clin Exp Res 2009; 33:1329-1335
23. 3 receptor antagonist, ondansetron, blocks the development and expression of ethanol-induced locomotor sensitization in mice. Behav Pharmacol 2009; 20:78-83
24. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994
25. Bohn MJ, Babor TF, Kranzler HR: The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol 1995; 56: 423-432
26. Stout RL, Wirtz PW, Carbonari JP, Del Boca FK: Ensuring balanced distribution of prognostic factors in treatment outcome research. J Stud Alcohol Suppl 1994; 12:70-75
27. Sobell LC, Sobell MB: Timeline follow-back: a technique for assessing self-reported alcohol consumption, in Measuring Alcohol Consumption: Psychosocial and Biochemical Methods. Edited by Litten RZ, Allen JP. Totowa, NJ, Humana Press, 1992, pp 41-72
28. Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J: Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial. JAMA 2000; 284:963-971 (Pubitemid 30659126)
29. Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Addolorato G, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS, Swift RM; Topiramate for Alcoholism Advisory Board, Topiramate for Alcoholism Study Group: Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment. Arch Intern Med 2008; 168: 1188-1199
30. Levine J, Schooler NR: SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull 1986; 22:343-381 (Pubitemid 16043808)
31. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM: Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar). Br J Addict 1989; 84:1353-1357 (Pubitemid 19281139)
32. US Department of Health and Human Services: Cognitive-Behavioral Coping Skills Therapy Manual (NIH Pub 92-1895). Washington, DC, US Department of Health and Human Services, 1992
33. Monti PM, Abrams DB, Kadden R, Cooney N: Treating Alcohol Dependence: A Coping Skills Training Guide. New York, Guilford, 1989
34. Marlatt GA, Gordon JR: Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York, Guilford, 1985
35. Bandura A: Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977; 84:191-215
36. Wendland JR, Martin BJ, Kruse MR, Lesch KP, Murphy DL: Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry 2006; 11:224-226
37. Mao X, Bigham AW, Mei R, Gutierrez G, Weiss KM, Brutsaert TD, Leon-Velarde F, Moore LG, Vargas E, McKeigue PM, Shriver MD, Parra EJ: A genomewide admixture mapping panel for Hispanic/Latino populations. Am J Hum Genet 2007; 80:1171-1178 (Pubitemid 47579352)
38. Kosoy R, Nassir R, Tian C, White PA, Butler LM, Silva G, Kittles R, Alarcon-Riguelme ME, Gregersen PK, Belmont JW, De La Vega FM, Seldin MF: Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum Mutat 2009; 30: 69-78
39. Cohen J: Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ, Lawrence Erlbaum Associates, 1988
40. SAS Institute: SAS, version 9.1. Cary, NC, SAS Institute, 2003
41. Hamer RM, Simpson PM: Last observation carried forward versus mixed models in the analysis of psychiatric clinical trials (editorial). Am J Psychiatry 2009; 166:639-641
42. Little R, Rubin DB: Statistical Analysis With Missing Data, 2nd ed. New York, John Wiley & Sons, 2002
43. Wulfsohn MS, Tsiatis AA: A joint model for survival and longitudinal data measured with error. Biometrics 1997; 53:330-339 (Pubitemid 27131905)
44. Vonesh EF, Greene T, Schluchter MD: Shared parameter models for the joint analysis of longitudinal data and event times. Stat Med 2006; 25:143-163 (Pubitemid 43136954)
45. Liu L: Joint modeling longitudinal semi-continuous data and survival, with application to longitudinal medical cost data. Stat Med 2009; 28:972-986
46. Hollingshead AB, Redlich FC: Social Class and Mental Illness: A Community Study. New York, John Wiley & Sons, 1958
47. Kenna GA, Zywiak WH, McGeary JE, Leggio L, McGeary C, Wang S, Grenga A, Swift RM: A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline. Alcohol Clin Exp Res 2009; 33:315-323
48. Cherpitel CJ, Bond J, Ye Y: Alcohol and injury: a risk function analysis from the Emergency Room Collaborative Alcohol Analysis Project (ERCAAP). Eur Addict Res 2006; 12:42-52 (Pubitemid 41797963)
49. Dawson DA: Alcohol and mortality from external causes. J Stud Alcohol 2001; 62:790-797
50. Dawson DA: Alcohol, drugs, fighting, and suicide attempt/ideation. Addict Res 1997; 5:451-472
51. Wechsler H, Nelson TF: Relationship between level of consumption and harms in assessing drink cut-points for alcohol research: commentary on "Many college freshmen drink at levels far beyond the binge threshold" by White et al. Alcohol Clin Exp Res 2006; 30:922-927
52. Penberthy JK, Ait-Daoud N, Breton M, Kovatchev B, DiClemente CC, Johnson BA: Evaluating readiness and treatment seeking effects in a pharmacotherapy trial for alcohol dependence. Alcohol Clin Exp Res 2007; 31:1538-1544 (Pubitemid 47319656)
53. Johnson BA, Cloninger CR, Roache JD, Bordnick PS, Ruiz P: Age of onset as a discriminator between alcoholic subtypes in a treatment-seeking outpatient population. Am J Addict 2000; 9:17-27 (Pubitemid 30155030)
54. Kenna GA: Pharmacotherapy of alcohol dependence: targeting a complex disorder. Drug Discov Today Ther Strateg 2005; 2:71-78
55. Hallikainen T, Saito T, Lachman HM, Volavka J, Pohjalainen T, Ryynänen O-P, Kauhanen J, Syvälahti E, Hietala J, Tiihonen J: Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior. Mol Psychiatry 1999; 4:385-388 (Pubitemid 29440580)